1.
Yang H-S, Yu L, White CC, et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study. Lancet Neurol. 2018;17(9):773-781. doi:10.1016/S1474-4422(18)30251-5.
1.
Dunn EC, Crawford KM, Soare TW, et al. Exposure to childhood adversity and deficits in emotion recognition: results from a large, population-based sample. J Child Psychol Psychiatry. 2018;59(8):845-854. doi:10.1111/jcpp.12881.
1.
Milliren CE, Evans CR, Richmond TK, Dunn EC. Does an uneven sample size distribution across settings matter in cross-classified multilevel modeling? Results of a simulation study. Health Place. 2018;52:121-126. doi:10.1016/j.healthplace.2018.05.009.
1.
Yu L, Petyuk VA, Gaiteri C, et al. Targeted brain proteomics uncover multiple pathways to Alzheimer’s dementia. Ann Neurol. 2018;84(1):78-88. doi:10.1002/ana.25266.
1.
Yu L, Chibnik LB, Srivastava GP, et al. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015;72(1):15-24. doi:10.1001/jamaneurol.2014.3049.
1.
Dunn EC, Richmond TK, Milliren CE, Subramanian SV. Using cross-classified multilevel models to disentangle school and neighborhood effects: an example focusing on smoking behaviors among adolescents in the United States. Health Place. 2015;31:224-32. doi:10.1016/j.healthplace.2014.12.001.